Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass ivermectin administration for community scabies control in rural north India
ACTRN12619001712190Phase 4Recruiting
- Sponsor
- Nossal Institute for Global Health
- Start
- Jan 2020
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ivermectin and permethrin in scabies, sponsored by Nossal Institute for Global Health. Primary endpoint: Community prevalence of scabies. Started Jan 2020; status: recruiting.
02
Drugs
ivermectinpermethrin
03
Conditions
scabies
Beyond the preview
Go deeper on ACTRN12619001712190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001712190.